14 results
Sort by:
In: Political science quarterly: a nonpartisan journal devoted to the study and analysis of government, politics and international affairs ; PSQ, Volume 114, Issue 3, p. 509-510
ISSN: 1538-165X
In: Diplomatic history, Volume 21, Issue 1, p. 139-148
ISSN: 1467-7709
In: Diplomatic history, Volume 19, Issue 4, p. 549-568
ISSN: 1467-7709
In: The journal of politics: JOP, Volume 57, Issue 2, p. 309-323
ISSN: 1468-2508
In: The journal of politics: JOP, Volume 57, Issue 2, p. 309-323
ISSN: 0022-3816
In: Public choice, Volume 78, Issue 1, p. 3-22
ISSN: 0048-5829
In: Public choice, Volume 78, Issue 1, p. 3-21
ISSN: 1573-7101
In: Comparative political studies: CPS, Volume 33, Issue 5, p. 690
ISSN: 0010-4140
In: Orbis: FPRI's journal of world affairs, Volume 46, Issue 1, p. 159-172
ISSN: 0030-4387
In: Orbis: FPRI's journal of world affairs, Volume 46, Issue 1, p. 159-172
ISSN: 0030-4387
World Affairs Online
In: Comparative political studies: CPS, Volume 33, Issue 5, p. 686-693
ISSN: 1552-3829
In: Political science quarterly: PSQ ; the journal public and international affairs, Volume 114, Issue 3, p. 509
ISSN: 0032-3195
Background: Approximately 50% of pharmacy prescriptions in the United States are filled with generic drugs, which have improved substantially in quality owing to increased governmental regulations. The remaining medicoeconomic question regards whether or not brand-name medications are worth the price. This study evaluates these questions for the brand-name mood stabilizer divalproex sodium and its generic counterpart, valproic acid.
BASE
